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Abstract: Clinical advances in the treatment of dentoalveolar defects 
continue to evolve with the introduction of new innovations in regenerative 
medicine and tissue bioengineering. Recent developments in tissue 
engineering are aimed at safely and effectively regenerating a damaged or 
necrotic area by replenishing its cells and increasing surrounding gene 
expression. Various techniques have successfully given rise to porous 
scaffolds being used by clinicians to treat the defect and initiate the repair 
process. Tissue reconstruction using bioengineered scaffolds is advantageous 
over traditional autografting, since it prevents the instigation of pain and 
donor site morbidity while ultimately creating both the environment and 
machinery needed to induce cell proliferation, migration, and reattachment 
within the affected area. This review article aims to describe and review the 
available literature regarding the regenerative capacity of natural polymers 
used for the treatment of dentoalveolar defects. The repair mechanisms, 
advantages of protein and polysaccharide derivatives, and the potential of 
stem cell therapy are discussed. 
Bone resorption is a progressive process that complicates 
restoration of edentulous and partially edentulous areas.1,2 Bone loss 
compromises the periodontal health of teeth, complicates placement of 
dental implants3 and in advanced cases may cause remarkable 
changes in facial morphology.4 
Tissue regeneration in the form of grafting using bone 
substitutes is used extensively for patient treatment. Every year in the 
United States, approximately 500,000 bone grafting procedures are 
performed in dental and medical offices. The market for bone 
substitutes used in these procedures is valued near 1 billion dollars.5 
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In 2012, the market for biomaterials used exclusively in dental 
procedures was valued at 222 million dollars, and this number 
continues to grow.6 
With the advent of tissue engineering, specific materials and 
scaffolds have been produced to effectively deliver synthetic and 
biological agents capable of tissue regeneration.7-17 Scaffolds must 
effectively facilitate the early stages of regeneration before 
transitioning to a natural mode of self-repair.18-26 In addition to 
delivering regenerative biomaterials, scaffolds seal off the affected 
area and protect it from infection, restore the extracellular matrix 
(ECM), and induce proliferation and differentiation of cells composing 
the four primary types of dental tissue: bone, cementum, connective 
tissue, and gingival epithelium.27,28 Therefore, scaffolds can be used in 
various dental applications and preprosthetic surgery including guided 
tissue regeneration and treatment of periodontal disease,29 osteogenic 
repair of the alveolar process and bone augmentation procedures to 
increase volume of bone and restore bony defects prior to endosseous 
implant surgery, craniofacial bone defect repair,30 socket preservation 
procedures, and in the treatment of ailing/failing dental implants.31 
In the last decade, the use of bioprinted scaffolds composed of 
natural polymers and stem cells has remarkably allowed for repair of 
an array of defects while mimicking the human ECM.32 The ECM 
contains molecules that contribute to the strength and flexibility of the 
periodontium.33 The presence of growth factors in the matrix is 
important in the process of regeneration, and the combination of 
abundant biomolecules and signaling mechanisms within the ECM 
assists in the differentiation of progenitor cell populations, replenishing 
the mature cells native to a healthy bone and gingival tissue.34,35 
Strong adhesion of cells to ECM proteins holds functional necessity, is 
vital to tissue integrity, and is a significant goal in restoring the 
chemical nature of the environment to be restored and augmented.36 
The focus of this manuscript is to review materials used in 3D 
bioprinting of scaffolds, including polysaccharide derivatives, protein 
derivatives, and stem cells, that can restore the necessary interaction 
between the cells and matrix in preprosthetic surgery requiring tissue 
engineering. Nearly 100 papers in journals from both the United States 
and abroad dating from 1972 until 2015 were used to compile 
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information regarding the application of each polymer in the 
regeneration of dentoalveolar and maxillofacial tissues. Papers 
focusing on biomaterial characteristics and the clinical effects of tissue 
engineering were analyzed alike and cited to write the manuscript on 
this multidisciplinary topic. 
Polysaccharide derivatives 
Chitosan 
Chitosan is a biopolymer obtained from chitin, a nitrogen-
containing polysaccharide derived from glucose. Chitosan is 
biocompatible, flexible, and antibacterial and can accelerate wound 
healing.37 It can be shaped into various structures, including 
microspheres,38 paste,39 sponges,40 and porous scaffolds,41 and 
therefore, it has the potential to be used in tissue engineering.42 Lahiji 
et al43 noted that chitosan can be successfully used as a template for 
bone defect restorations, due to its ability to support viable 
osteoblasts. A study on the effects of chitosan on socket preservation 
after extraction showed that the bone densities in the middle and 
apical sections of the repaired socket were significantly greater in 
chitosan-treated sockets than the untreated, unfilled control group, 
concluding that it can be used for bone repair in the cases of bone 
loss.44 In another study, chitosan was used to restore bony defects in 
the upper tibia of rats. The results showed that compared to the 
control, in which chitosan powder was not used to fill the defect, bone 
repair was significantly expedited in the chitosan group at 1 week and 
4 weeks post-surgery.45 Further attesting to chitosan potential in 
tissue engineering, Muzzarelli et al46 demonstrated that chitosan 
ascorbates produced in the gel form are fit for the regeneration of 
periodontal ligament (PDL) tissues. They also demonstrated that the 
chitosan was gradually reabsorbed in hosts with a satisfactory clinical 
recovery of periodontal defects, where both tooth mobility and pocket 
depths were significantly reduced. 
Because of its biocompatibility and bioactivity, chitosan can be 
combined with several inorganic materials to make 3D microstructures 
to be used as scaffolds. Examples of these inorganic materials include 
bioactive glass, hydroxyapatite, alginate, collagen, and recombinant 
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vectors. Bioactive glass, as the name implies, has excellent bioactivity 
and when added to chitosan membranes would promote guided bone 
regeneration.37 Mota et al37 showed that membranes containing 
chitosan/bioactive glass nanoparticles, in contrast to pure chitosan 
membranes, were able to stimulate the deposition of an apatite layer, 
which highlights the advantages of a composite scaffold. 
Another inorganic material that can be combined with chitosan 
is hydroxyapatite, which is known for its biocompatibility and its 
osteoconductive potential.47,48 Kong et al49 developed a homogenous 
nanohydroxyapatite/chitosan porous scaffold that possessed better 
biocompatibility than a pure chitosan scaffold, while also allowing a 
higher proliferation of cells. In agreement with Kong et al's findings, 
Zhang et al50 concluded that a nanohydroxyapatite/chitosan scaffold 
had better cytocompatibility than a pure chitosan scaffold. 
Other materials have been used to enhance the strength of 
chitosan-based scaffolds. Li et al51 used alginate to construct a 
chitosan/alginate composite with significantly enhanced mechanical 
strength. The chitosan/alginate scaffold allowed seeded osteoblasts to 
attach and proliferate well in culture without the use of an osteogenic 
medium and promoted quicker deposition of minerals compared to 
pure chitosan. 
Zhang et al52 used chitosan/collagen scaffolds to create a porous 
structure that could be loaded with plasmids and adenoviral vectors 
encoding human transforming growth factor-β1 (TGF-β1). Human PDL 
cells were seeded within the scaffold's pores and implanted into 
athymic mice. It was found that no inflammatory reaction or 
extrusions occurred, confirming the biocompatibility of this TGF-β1 
encoding scaffold. This scaffold also showed the highest proliferation 
rate as well as upregulated expression of both type I and type III 
collagen. Moreover, tagged human PDL cells caused surrounding 
tissues to grow within the porous scaffolds. The study concluded that 
the chitosan/collagen composite scaffold encoding TGF-β1 is a 
candidate that could work well for periodontal tissue regeneration. 
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Cellulose 
Cellulose membranes were the first biomaterial employed as 
surgical barriers for guided tissue regeneration, followed by expanded 
polytetrafluoroethylene (ePTFE) and some other biodegradable 
polymers.53-55 Cellulose and ePTFE have been introduced with the 
commercial names of Millipore filter and Gore-Tex as non-resorbable 
biomaterials for cell-occlusive barriers used for tissue regeneration.55 
As a relevant form of cellulose in tissue engineering, microbial 
cellulose (MC) is a polysaccharide that has been developed from 
Acetobacterxylinum.56 In addition to its use in the treatment of 
periodontal defects, guided-tissue regeneration, and preprosthetic 
surgery, MC membranes offer many other applications in regenerative 
medicine, including their use as a graft for dura mater surrounding 
brain tissues.56 MC has been previously used in wound-healing, 
confirming its promise as a product in the biomaterials field.56 MC 
membranes have been employed as a scaffold material to increase cell 
attachment.57 Wan et al58 synthesized a MC membrane coated with 
hydroxyapatite and found that mesenchymal stem cells (MSC) 
attached and proliferated onto the MC membrane with a low 
inflammatory response.58 
In vivo studies using MC demonstrated that MC samples did not 
cause any macroscopic inflammatory responses after 1 and 3 weeks of 
implantation,56 confirming findings from in vitro experiments.58 MC has 
also been used as a physical barrier in periodontal regeneration, to 
separate incised oral epithelial cells and gingival connective tissue 
from the treated root surface, allowing PDL cells to proliferate inside 
the treated area, leading to tissue regeneration.56,59 
Another form of cellulose used in tissue engineering is cellulose 
hydrogels. They have been shown to be biocompatible with connective 
tissues. In vitro experiments on cellulose hydrogels revealed that this 
material has potential to enhance osteoblast cell attachments and 
proliferation for bone tissue engineering.60 
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Protein derivatives 
Collagen 
Collagen, an extremely abundant protein and defining 
component of connective tissue throughout the body, is a potent 
biomaterial with a vast potential for tissue regeneration. Examples of 
collagen's beneficial role during tissue repair include surrounding 
tissue compatibility, biodegradability, induction of epithelial 
regeneration,61 and its low immunogenicity and cytotoxicity.62 More 
specifically, due to its low immunogenicity, collagen fosters the growth 
of a native ECM, is chemotactic for fibroblasts, and induces a cascade 
by which the internal matrix is further developed.63 
Collagen has a strong osteoinductive effect, stimulating 
osteoblast differentiation and proliferation, which would lead to bone 
growth. Collagen also increases gene expression for morphogenic 
proteins, such as BMP.44 To engineer skeletal tissues, a scaffold should 
contain a significant number of progenitor cells in addition to bioactive 
agents that can draw in cells with a restorative functionality to the site 
of damage.64,65 Collagen plays a crucial role in facilitating this biological 
process because it acts as an anchor for the attachment of 
proteoglycans and glycosaminoglycans, improving the overall 
mechanical strength and stability of the regenerated tissue.66 While 
collagen's inductive role in BMP expression has demonstrated a strong, 
notable regeneration of the peri-implant and periodontal defects, 
previous in vivo studies demonstrate that duration of BMP availability 
and activity in scaffolds is limited.67 
The rehabilitative potential of collagen in tissue engineering lies 
primarily in its use for delivering plasmids and adenoviral vectors. For 
example, a study examining the combination of adenovirus encoding 
PDGF-B (AdPDGF-B) with a collagen gel noted an increase in the area 
of cementum, filling of alveolar defects, and an increase in bone 
volume.68 However, the target tissue and type of collagen in the 
scaffold are important factors to consider because different types of 
collagen may provide different degrees of biocompatibility, 
immunogenicity, degradation rates, and different mechanical 
properties of the scaffold.69,70 For example, types I and III collagen are 
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known to make up the PDL,71 and type IV collagen makes up the 
basement membrane of junctional epithelium and the epithelial rests 
of the PDL.72 
Fibrin 
As a natural protein, fibrin is synthesized from fibrinogen, which 
may be autologously harvested from the human body.73 Polymerized 
fibrin is a main constituent of blood clots and has an important 
function in the later wound-healing processes.74 Due to its natural 
ability to enhance cellular interaction and follow scaffold remodeling 
compared to the synthetic scaffolds, fibrin has found a well-established 
application in various areas of research in regenerative dentistry.75 
Fibrin provides a biocompatible carrier for biomolecules and presents a 
substrate for adhesion of tissue-forming cells such as endothelial cells, 
and fibroblasts, which are engaged in angiogenesis and are responsible 
for remodeling of the new regenerated tissues.76 
Fibrin provides suitable locations for cell-substrate binding, and 
therefore it mimics the native tissue77 and allows for remodeling by 
cell-associated proteolytic activity.78 Fibrin gel has been produced 
recently with a shape of three-layered human PDL cell sheets and 
transplanted with a human dentin block subcutaneously into the back 
of a rat. The results of histological evaluations revealed that the 
human PDL cells/dentin blocks stimulated a new cementum-like hard 
tissue on the surfaces of more than 60% of the samples after 6 weeks 
of implantation.79 
Fibrin glue has also been used with periosteal cell/matrix 
hybrids to form new bone at heterotopic sites in nude mice. The 
periosteal cells were mixed with fibrin glue in a syringe, and then the 
cell/matrix-fibrin glue was injected on the dorsum of athymic nude 
mice. After 3 months, histological evaluations confirmed the ability of 
fibrin glue carrier to cause new bone formation.80 
Fibrin enhances the mitogenic response of the periosteum 
during the bone-healing process by trapping and activating platelets 
that cause the secretion of growth factors, such as platelet-derived 
growth factor, transforming growth factor, and insulin-like growth 
factor I.81,82 Choukroun et al83 developed a fibrin matrix known as a 
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platelet-rich fibrin (PRF) in order to hold platelet cytokines and cells 
before releasing them after a predetermined time. Gassling et al76 
showed that PRF is an excellent scaffold material for proliferation of 
human periosteal cells, with a great potential for use in tissue 
engineering; however, the imperative property of PRF is a profit not 
only due to its biocompatibility, but also because of its lower costs.76 
Numerous researchers have confirmed fibrin as an appropriate 
scaffold for adherence, colonization, and profileration of human 
mesenchymal stem cells (HMSC).84,85 Therefore, using fibrin as an 
autologous scaffold for periosteal cell or stem cell transplantation and 
for bone tissue engineering is a promising application; however, its 
fast biodegradability may be a disadvantage for its use as a shape-
specific scaffold in tissue engineering. Thus, optimizing fibrin 
composition is an area requiring further research to acquire a scaffold 
system that provides the best shape integrity.75 
Stem cells 
Preclinical investigations revealed that stem cell delivery can be 
used to create consistent and efficient outcomes in managing dental 
and orofacial defects,86,87 so that some clinical trials employing in vitro 
expanded stem cells have begun or are in progress. The first clinical 
alveolar bone reconstruction was conducted in 2009 using dental pulp 
stem cells (DPSCs). This work proposed that a dental pulp stem 
cells/collagen sponge biocomplex can entirely repair human mandible 
defects and demonstrated that this cell population could be employed 
for the regeneration of organs. In 2011, there was an approved clinical 
study for periodontal regenerative therapy using cell sheet technology. 
The results of this work indicated that the use of autologous PDL cell 
sheets and β-tricalcium phosphate (β-TCP) could restore the defects of 
alveolar bone and PDL tissue.86,87 
Due to the lack of native stem cells, tissue regeneration does 
not naturally occur in bone defects. For this reason, exogenous 
regenerative materials including in vitro manipulated stem cells are 
required to encourage the host cell niche and help tissue repair.88 
Stem cells and/or progenitor cells are typically cultured ex vivo and 
used to treat patients as biological agents.89 A promising source of 
stem cells needs to have high proliferation ability, ability to 
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differentiate into intended types of cells, low antigenicity, and easy 
manipulation into expanded processing. PDL stem cells (PDLSCs), 
stem cells from apical papilla (SCAP), stem cells from human 
exfoliated deciduous teeth (SHED), and bone marrow mesenchymal 
stem cells (BMMSCs) are the common potential cell sources being 
employed in dental tissue engineering.87,89 These cells are isolated 
from the dental tissue, bone marrow, and adipose, and then they are 
proliferated and implanted into the periodontal defect using either 
biomaterial-free or biomaterial-based scaffolds.90 Otherwise, the cells 
may be allogeneic from a cell bank.87 Recent reports have shown that 
MSC have been used for the regeneration of PDL, cementum, and 
alveolar bone in vivo.90,91 
BMSCs can be used practically in periodontal tissue 
engineering.91-93 In one study, biodegradable collagen as the 
biomaterial scaffold supported BMSCs during implantation.94 The 
results of another study on the implantation of cultured human PDL 
stem cells into the produced periodontal defects in rats demonstrated 
that the stem cells were adhered to both the alveolar bone and 
cementum surfaces, and there was an indication of the development of 
a PDL-like structure.95,96 Stem cell therapy will need to consider the 
costs, provide help to patients, satisfy regulatory agencies, meet 
enhanced stem cell supplies, be covered by medical insurance, and 
prove lucrative for pharmaceutical companies to get to the final stages 
of clinical applications.87 
Summary 
The applications of natural polymers have proven to be 
extremely potent in preprosthetic surgery and in periodontal tissue 
regeneration. In every substance, the biocompatibility and induction of 
cell migration and attachment are essential for a successful repair. 
Although minor differences exist between the polysaccharide and 
protein derivatives, the overall goal is that scaffold implantation and 
cellular activity guides regeneration of all components of the 
periodontium. These biological agents target the soft tissue and 
underlying hard tissue, and the addition of a growth factor can further 
stimulate vascularization and osteoprogenitor differentiation, for 
example, to repair the resorbed bone. The mimicry of a native matrix 
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allows for normal biochemical processes. A leading candidate for 
alternative treatment, stem cell therapy, was also examined. In vitro 
testing has shown that stem cells hold great promise for the future of 
regenerative dentistry. All the natural origin polymers covered in this 
mini review (Table 1) are the most widely recognized treatment 
agents, and we have demonstrated comprehensively, with the support 
of material characteristics and clinical applications (Table 2), that the 
potential for each can induce repair of periodontal and craniofacial 
defects. 
Table 1. Summarized material characteristics 
  Chitosan Cellulose Collagen Fibrin 
Advantages –Biocompatible 
–Antibacterial 
–Wound 
healing 
–Enhanced cell 
attachment 
–No 
macroscopic 
inflammatory 
effect 
–Low 
immunogenicity 
–Strong 
osteoconductivity 
–Mimics native 
tissue 
–Enhances 
mitogenic 
response of 
periosteum 
Disadvantages –Poor 
mechanical 
strength 
–Cytotoxic 
effects 
–Poor mechanical 
properties 
–Rapid 
biodegradability 
Suggested 
materials to 
form the potent 
composite 
–Bioactive 
glass 
–
Hydroxyapatite 
–Alginate 
–Collagen 
–
Hydroxyapatite 
–Chitosan 
–Pectin 
–Hydrogel 
–PLGA 
–Hyaluronic Acid 
–Hydroxyapatite 
–Bioglass 
–Collagen 
–Polyurethane 
–Hydroxyapatite 
–Calcium 
Phosphate 
–Polylactide 
Table 2. Summarized clinical applications 
  Chitosan Cellulose Collagen Fibrin 
Clinical mode 
of delivery 
–Nanofiber 
membrane for 
GTR 
–Sponge 
–Electrospun 
nanofibers 
–Bioactive 
coating 
–Surgical barrier 
placement for 
GTR 
–Injectable gels 
–3D scaffold 
–Porous sponge 
implantation 
–3D scaffold 
–Injectable gels 
–Fibrin gel 
–Fibrin glue 
–Fibrin 
microbeads 
–3D scaffold 
On-site 
advantages 
–One of the 
most potent 
curative 
materials used 
–Enhanced 
proliferation of 
human PDL cells 
–Enhanced 
angiogenesis 
–Has a unique 
nanofibrillar 
composition that 
mimics a perfect 
matrix for 
regeneration 
–Allows for rapid 
healing 
–Serves as a 
barrier against 
infection 
–Extremely 
biocompatible 
–Controls 
preodontoblast 
rearrangement 
and their 
adhesion to pulp 
tissue 
–Widely used in 
maxillofacial and 
–Instigates 
hemostasis and 
tissue bonding 
–Minimizes 
blood loss 
–Combats 
bacterial 
infection at the 
site of injury 
–Successful use 
of fibrin-based 
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  Chitosan Cellulose Collagen Fibrin 
alveolar bone 
grafting 
scaffold in 
regenerative 
endodontics 
observed as well 
as regeneration 
of peri-implant 
defects, socket 
preservation, 
and healing of 
sinus 
perforations 
Complications –Uncontrolled 
dissolution in 
some cases 
–Low durability 
under 
compression of 
maxillofacial 
bone 
–Inflammatory 
reaction noted in 
several in vivo 
studies for bone 
engineering 
–Lack of durability 
under 
compression of 
maxillofacial bone 
–Loses capacity to 
maintain space in 
humid 
environment 
–Animal allograft 
of collagen could 
transmit disease 
–Rapid 
shrinkage 
remains a 
serious concern 
for clinicians 
–Requires use as 
a composite 
scaffold to 
overcome low 
mechanical 
strength 
Study type –In vitro 
–In vivo 
–Clinical trial 
–In vitro 
–In vivo 
–Clinical trial 
–In vitro 
–In vivo 
–Clinical trial 
–In vitro 
–In vivo 
–Clinical trial 
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